CPH CHEMIE + PAPIER HOLDING AG Investors' Day : 14 June 2021
Wolfgang Grimm
Head of Packaging
The Perlen Packaging business model
2
© Perlen Packaging AG, Perlen
Strategy successfully pursued: net sales and EBIT increased
in CHF million
200
150
98 102
100
50
0.8%
0 | 0 | 1 |
2% p.a.
106 107 116
3.6% | ||
4.7% | 6.1% | |
4 | 5 | 7 |
8% p.a. | 20% | ||||||
162 | |||||||
153 | 153 | ||||||
15% | |||||||
118 | 110 | 119 | 130 | ||||
13.3% | |||||||
10% | |||||||
11.3% | |||||||
10.1% | |||||||
7.6% | 7.3% | 5% | |||||
4.3% | 5.3% | 15 | 17 | 22 | |||
5 | 6 | 9 | 10 | 0% | |||
Net sales raised by 8% p.a. since 2015
Substantial increases in EBIT and EBIT margin to currently 13.3% (2020)
2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Net sales | EBIT | EBIT in % | ||
Targeted implementation of business strategy over the past few years
Consistent focus on the pharmaceutical market and on packaging films with the highest barrier properties Product development with expansion of the product range to higher-valuehigh-barrier films Processes enhanced, productivity increased and efficiencies improved at all sites and locations
Internationalization: international distribution organization established and new coating plants built in Asia (China) and Latin America (Brazil)
Strong innovative credentials: numerous awards for product innovations such as Perlazid (2009 IHZ Innovation Award) and BLISTair (2017 IHZ Innovation Award and further international distinctions in 2017 and 2018)
3
© Perlen Packaging AG, Perlen
The global pharmaceutical market and market trends
4
© Perlen Packaging AG, Perlen
The pharma markets in 2020-2025 in USD billion
585 | 635 | 370 | 445 | ||||||||||
291 | 308 | ||||||||||||
528 | 274 | 290 | |||||||||||
2020 | 2023 | 2025 | ||||||||||
2020 | 2023 | 2025 | ||||||||||
Europe | ||||||||||||
USA | CAGR 2%-4% | |||||||||||
CAGR 2%-5% | ||||||||||||
309 | 347 | |||||||||||
100 | 113 | 128 | 275 | |||||||||
2020 | 2023 | 2025 | 2020 | 2023 | 2025 |
Latin America | Asia, Africa, Australia | ||||
CAGR 5%-8% | CAGR 5%-7% | ||||
2020 2023 2025
Emerging economies*
CAGR 7%-10%
88 86 84
2020 2023 2025
Japan
CAGR -2%-1%
Pharmaceutical market
2020-2025
CAGR 3%-6%
Source: IQVIA Pharma Prognosis Dec 2019
© Perlen Packaging AG, Perlen
"Emerging economies" = *(Brazil, Russia, India, China, Mexico, Turkey, South Korea) | 5 |
included in the other regions | |
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original document
- Permalink
Disclaimer
CPH Chemie + Papier Holding AG published this content on 14 June 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 June 2021 08:00:01 UTC.
